BIGT.L vs. HLTW.L
Compare and contrast key facts about L&G Pharma Breakthrough UCITS ETF (BIGT.L) and Lyxor UCITS MSCI World Health Care TR C-USD (HLTW.L).
BIGT.L and HLTW.L are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BIGT.L is a passively managed fund by Legal & General that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on Jan 18, 2018. HLTW.L is a passively managed fund by Amundi that tracks the performance of the MSCI World/Health Care NR USD. It was launched on Aug 19, 2010. Both BIGT.L and HLTW.L are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
BIGT.L vs. HLTW.L - Performance Comparison
Loading graphics...
BIGT.L vs. HLTW.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
BIGT.L L&G Pharma Breakthrough UCITS ETF | 2.31% | 27.03% | -3.16% | -14.88% | 2.68% | -2.30% | 23.89% | 9.47% | -1.85% |
HLTW.L Lyxor UCITS MSCI World Health Care TR C-USD | -1.98% | 7.49% | 2.14% | -2.07% | 5.56% | 21.73% | 9.62% | 18.18% | 5.78% |
Different Trading Currencies
BIGT.L is traded in GBp, while HLTW.L is traded in USD. To make them comparable, the HLTW.L values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, BIGT.L achieves a 2.31% return, which is significantly higher than HLTW.L's -1.98% return.
BIGT.L
- 1D
- 1.91%
- 1M
- 1.91%
- YTD
- 2.31%
- 6M
- 8.11%
- 1Y
- 27.45%
- 3Y*
- 4.50%
- 5Y*
- 2.83%
- 10Y*
- —
HLTW.L
- 1D
- 1.87%
- 1M
- -4.21%
- YTD
- -1.98%
- 6M
- 6.23%
- 1Y
- 3.50%
- 3Y*
- 3.22%
- 5Y*
- 6.18%
- 10Y*
- 9.10%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BIGT.L vs. HLTW.L - Expense Ratio Comparison
BIGT.L has a 0.49% expense ratio, which is higher than HLTW.L's 0.30% expense ratio.
Return for Risk
BIGT.L vs. HLTW.L — Risk / Return Rank
BIGT.L
HLTW.L
BIGT.L vs. HLTW.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for L&G Pharma Breakthrough UCITS ETF (BIGT.L) and Lyxor UCITS MSCI World Health Care TR C-USD (HLTW.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BIGT.L | HLTW.L | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.38 | 0.22 | +1.16 |
Sortino ratioReturn per unit of downside risk | 1.90 | 0.41 | +1.49 |
Omega ratioGain probability vs. loss probability | 1.24 | 1.05 | +0.19 |
Calmar ratioReturn relative to maximum drawdown | 2.98 | 0.55 | +2.42 |
Martin ratioReturn relative to average drawdown | 8.68 | 1.12 | +7.56 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BIGT.L | HLTW.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.38 | 0.22 | +1.16 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.17 | 0.45 | -0.28 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.59 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.24 | 0.82 | -0.58 |
Correlation
The correlation between BIGT.L and HLTW.L is 0.67, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
BIGT.L vs. HLTW.L - Dividend Comparison
Neither BIGT.L nor HLTW.L has paid dividends to shareholders.
Drawdowns
BIGT.L vs. HLTW.L - Drawdown Comparison
The maximum BIGT.L drawdown since its inception was -30.23%, which is greater than HLTW.L's maximum drawdown of -18.93%. Use the drawdown chart below to compare losses from any high point for BIGT.L and HLTW.L.
Loading graphics...
Drawdown Indicators
| BIGT.L | HLTW.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.23% | -26.58% | -3.65% |
Max Drawdown (1Y)Largest decline over 1 year | -11.62% | -9.73% | -1.89% |
Max Drawdown (5Y)Largest decline over 5 years | -30.23% | -19.19% | -11.04% |
Max Drawdown (10Y)Largest decline over 10 years | — | -26.58% | — |
Current DrawdownCurrent decline from peak | -1.88% | -6.33% | +4.45% |
Average DrawdownAverage peak-to-trough decline | -10.72% | -5.17% | -5.55% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.41% | 3.55% | -0.14% |
Volatility
BIGT.L vs. HLTW.L - Volatility Comparison
L&G Pharma Breakthrough UCITS ETF (BIGT.L) has a higher volatility of 7.53% compared to Lyxor UCITS MSCI World Health Care TR C-USD (HLTW.L) at 5.07%. This indicates that BIGT.L's price experiences larger fluctuations and is considered to be riskier than HLTW.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BIGT.L | HLTW.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.53% | 5.07% | +2.46% |
Volatility (6M)Calculated over the trailing 6-month period | 14.17% | 9.74% | +4.43% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.80% | 16.10% | +3.70% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.69% | 13.79% | +2.90% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.36% | 15.32% | +3.04% |